4//SEC Filing
Chung Jane 4
Accession 0001415889-25-007182
CIK 0001382101other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:06 PM ET
Size
9.0 KB
Accession
0001415889-25-007182
Insider Transaction Report
Form 4
Chung Jane
PRESIDENT AND COO
Transactions
- Exercise/Conversion
Common Stock
2025-03-04+7,875→ 100,642 total - Tax Payment
Common Stock
2025-03-04$1.42/sh−2,334$3,314→ 98,308 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2025-03-04−7,875→ 7,875 totalExp: 2026-03-04→ Common Stock (7,875 underlying)
Footnotes (3)
- [F1]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.
- [F2]Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
- [F3]The RSUs vest as to 1/4th of the total award annually beginning on March 4, 2023, subject to continued service through each vesting date.
Documents
Issuer
SUTRO BIOPHARMA, INC.
CIK 0001382101
Entity typeother
Related Parties
1- filerCIK 0001872398
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 4:06 PM ET
- Size
- 9.0 KB